Results 301 to 310 of about 629,305 (401)

Overexpression of BPIFB4 Alleviates COPD Inflammatory Damage by Inhibiting M1 Macrophage Activation via the PI3K/AKT Pathway [PDF]

Lili Xue, Jingran Xu, Hui Gong, Zulipikaer Abudureheman, Ayiguli Alimu, Yun Chen, Aifang Zheng, Liang Gao, Xiuqi Lu, Chengxin Xie, Li Li   +10 more
openalex   +1 more source

Global burden of COPD: systematic review and meta-analysis

European Respiratory Journal, 2006
R. Halbert, J. L. Natoli, J. L. Natoli, Anacleto D Gano, E. Badamgarav, A. Buist, D. Mannino   +6 more
semanticscholar   +1 more source

Beta‐blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

European Journal of Heart Failure, EarlyView.
In total, 5084 patients from Swedish registries with both heart failure (HF) with reduced ejection fraction (HFrEF) and chronic obstructive pulmonary disease (COPD) were included. Confounding was handled by overlap weighting based on propensity scores for beta‐blocker use. Patients were followed up for 5 years, or until death, emigration from Sweden or
Benedikt N. Beer, Lina Benson, Christian Basile, Benedikt Schrage, Peter Moritz Becher, Stefan Blankenberg, Paulus Kirchhof, Barna Szabó‐Söderberg, Marco Metra, Anne Lindberg, Egidio Imbalzano, Giuseppe M. C. Rosano, Patric Karlström, Peter G.M. Mol, Raffaele Scorza, Lars H. Lund, Felix Lindberg, Gianluigi Savarese   +17 more
wiley   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

European Journal of Heart Failure, EarlyView.
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi, Kevin Duarte, João Pedro Ferreira, Guillaume Baudry, Luca Monzo, John J.V. McMurray, Dirk J Van Veldhuisen, Bertram Pitt, Faiez Zannad, Nicolas Girerd   +9 more
wiley   +1 more source

The impact of hyperglycemia on prognosis in chronic obstructive pulmonary disease patients with coronary heart disease: A five-year prospective study. [PDF]

PLoS One
Dai Z, He C, Zeng H, Chen Y.
europepmc   +1 more source

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

European Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, John G.F. Cleland, Sean P. Collins, Christiane E. Angermann, Kenneth Dickstein, Ulf Dahlstrom, Anja Schweizer, Achim Obergfell, Kai‐Hang Yiu, Mathieu Ghadanfar, Mahmoud Hassanein, Qing‐Wen Ren, Wen‐Li Gu, Georg Ertl, Sergio V. Perrone, Gerasimos Filippatos, Carolyn S.P. Lam, Jasper Tromp   +19 more
wiley   +1 more source

Heart rate variability associated with depression and lung decline in chronic obstructive pulmonary disease: Mechanisms and interventions. [PDF]

World J Psychiatry
Liu MH, Wu LL.
europepmc   +1 more source

Unsupervised machine learning for cardiovascular disease: A framework for future studies

European Journal of Heart Failure, EarlyView.
Unsupervised machine learning can improve the characterization and stratification of patients with cardiovascular diseases (CVDs). Clustering algorithms, which group patients based on patterns in clinical data, can reveal distinct subgroups that may differ in prognosis and treatment response.
Emmanuel Bresso, Claire Lacomblez, Kévin Duarte, Luca Monzo, Guillaume Baudry, Jasper Tromp, Abhinav Sharma, Nicolas Girerd   +7 more
wiley   +1 more source

Outpatient loop diuretic use and the effect of natriuresis‐guided diuretic therapy: A prespecified sub‐analysis of the PUSH‐AHF study

European Journal of Heart Failure, EarlyView.
The effects of natriuresis‐guided diuretic therapy in patients with acute decompensated heart failure, depending on outpatient loop diuretic use. HR, hazard ratio; NG, natriuresis‐guided; SOC, standard of care. Aims Diuretic resistance is frequently observed in patients with acute decompensated heart failure (ADHF), specifically in those with chronic ...
Lara E.E.C. Zonneveld, Iris E. Beldhuis, Hailun Qin, Dirk J. van Veldhuisen, Jenifer E. Coster, Wybe Nieuwland, Jan A. Krikken, Peter van der Meer, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten   +10 more
wiley   +1 more source

Cardiopulmonary risk in the COPD patient: the EPOCONSUL audit. [PDF]

Sci Rep
Calle Rubio M, Miravitlles M, López-Campos JL, Soler-Cataluña JJ, Alcázar-Navarrete B, Fuentes Ferrer ME, Rodríguez Hermosa JL.   +6 more
europepmc   +1 more source